Compound ID | 3395
PP1493 and PP1815
Class: Bacteriophage
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Staphylococcus aureus; intended indication for prosthetic joint infection |
| Description: | Bacteriophage from Pherecydes Pharma library; Silviavirus and Rosenblumvirus lytic phages from the environment |
| Institute where first reported: | AlgiPharma AS |
| Year first mentioned: | 2022 |
| Highest developmental phase: | Phase 2 (NCT05369104) |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.